Comparing two drugs for inflammation during heart bypass surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if dexmedetomidine or methylprednisolone is better at reducing inflammation during coronary artery bypass grafting (CABG) with a heart-lung machine. The goal is to find a treatment that helps patients recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 60 years old
- You are scheduled for coronary artery bypass surgery using a heart-lung machine
- You are in ASA class II or III (meaning you have mild to moderate health issues but are stable)
- You do not have severe liver or kidney disease, or a weak heart pump (ejection fraction less than 40%)
- You have not had a recent infection (within the last week) or used antibiotics or steroids before surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two common anesthesia medicines (etomidate and propofol) for patients having planned coronary artery bypass surgery. The goal is to see which medication works better for your heart and recovery.
This study looks at whether giving dexamethasone and olanzapine during certain heart surgeries can improve how blood flow and ventilation (breathing support) are managed. It’s meant to see if these medicines help the body handle heart-lung bypass more safely.
This trial is testing whether a single dose of the steroid methylprednisolone, given before heart surgery, can protect your kidneys from damage during the operation. If you qualify, you'll receive the drug or a placebo, and your kidney function will be monitored closely.
This trial tests if two different medicines, dexamethasone and dexmedetomidine, given as a nerve block in your nose during rhinoplasty can better control pain after surgery.
This study compares two medicines—pregabalin and dexmedetomidine—to treat confusion (called delirium) after heart bypass surgery. It aims to see which drug works better to reduce delirium symptoms in older adults after coronary artery bypass surgery.
This study tests adding a medicine called dexmedetomidine to a standard pain-blocking injection (ropivacaine) used during heart surgery. The goal is to see if it reduces pain and speeds recovery better than the injection alone.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.